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Abstract
Patients have ever-increasing access to web-based news about hopeful scientific develop-
ments that may or may not cure them in the future. Science communication experts agree
that the quality of news provision is not always guaranteed. However, literature does not
clarify in what way users are actually affected by typical news characteristics such as the
news object (described developmental phase of an innovation), the news source (degree of
authority), and the news style (degree of language intensification). An online vignette experi-
ment (N = 259) investigated causal relationships between characteristics of news about dia-
betes innovations and patients’ perceptions of future success, their interest in the
innovation, and attitudes regarding current therapy adherence. Findings show that descrip-
tions of success in mice led to higher estimations of future success chances than earlier and
later developmental phases. Furthermore, news from a nonauthoritative source led to an
increased interest in the innovation, and a more negative attitude towards current lifestyle
advice. Lastly, the intensification of the language used in news messages showed slight
adverse effects on the readers’ attitude. These findings, combined with their small effect
sizes, support the optimistic view that diabetes patients are generally critical assessors of
health news and that future research on this topic should focus on affected fragile
subgroups.
Introduction
In the present digital era, patients with a chronic condition frequently encounter news mes-
sages about the potential healing of their disease. No matter if the person is an active health
news seeker, or perhaps is trying to avoid such information, exposure to some extent seems
likely for many. A large number of digital platforms actively spread scientific research results,
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with varying goals [1, 2]. For example, web-based newspapers present readers with quality
interviews with scientists or patient organizations [3] acting as an information conduit for
their communities; social media platforms provide members with daily news updates often
from a highly personal perspective; academic and governmental news platforms and scientific
libraries often the actual primary source of new scientific results. This online news on scientific
health developments differs widely in important news characteristics such as news objects (i.e.
fragsments of contenst that receive a focus of the editor, such as the scientific developmental
phase of an innovation in the news), the news source (with a degree of authority), and the
news style (e.g. degree of language intensification). Given the unrestrained expansion of web-
based news sources, essential questions arise that yet require empirical answering in the scien-
tific literature: In what way do typical characteristics of news about innovative treatments affect
patient perceptions? The present study aims to obtain new insights into this topic in the context
of a chronic disease that receives a lot of media attention worldwide: diabetes mellitus.
Diabetes research in the news
Diabetes mellitus is one of the most widely spread chronic diseases and it receives much atten-
tion in academic papers as well as in newspapers and social media [4–6]. A quick scan in scien-
tific databases such as PubMed shows that, annually, tens of thousands of academic papers are
published about both diabetes mellitus type 1 and type 2, from which authors of health news
could potentially draw. Although significant progress towards a cure for diabetes is reported in
several publications, various promising innovative concepts have been covered for decades
without clinically adaptable results. Already in 1972, for example, a glucose sensor was devel-
oped that purportedly gave rise to optimism about a so-called ’self-contained totally implant-
able artificial organ that would continuously monitor sugar concentration in a body fluid of a
diabetic and meter out insulin in proportion to need’ [7]. The whole organ is presently referred
to as the artificial pancreas and is still under development. News media regularly report early
stages of medical research with innovative potential while remaining unclear about actual clin-
ical evidence from patients and thus about market potential. In fact, a study showed that less
than 1 out of 5 Dutch newspaper articles reporting innovative treatments for diabetes were
supported by an in-article reference to proven effects in actual patients [8].
Nonetheless, even the holy grail in research, the randomized controlled trial on actual
patients, may lack reliability and still reach media headlines. Weaker human trials have small
sample sizes or include patients with narrow inclusion criteria. It may also happen that they
detect evidence for effectivity, despite the fact that risk-benefit ratios of the treatment are unfa-
vorable due to high costs or side effects. Fortunately, several examples of media watchdogs
have arisen in the world to assess the quality of health news articles and to educate news editors
and the general public on interpreting the value of health claims [9, 10].
News object: Developmental phases in medical science
Developing new drugs or other medical therapies is a complicated and time-consuming pro-
cess. In addition to the lengthy process of discovering new molecules or refining smart tech-
niques and testing their effectiveness in laboratory settings, the subsequent clinical research
phase, involving experiments on smaller and larger groups of actual patients, can last years
and is not always successful. For example, innovations in the endocrine disease area that are
promising enough to be tested for safety on humans (i.e., phase 1 clinical research) have a
chance of about 14% to be eventually approved for the market, which is between 6 and 9 years
later [11]. The development of new medical applications can take decades and follows distinct
phases, from first ideas to actual market access. In the earliest stages of research, evidence from
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observational studies (e.g., correlations with food) or evidence from fundamental research
may lead to animal-testing, clinical testing in small groups of humans, or encourage invest-
ments in innovative technologies. Randomized clinical trials in patient populations provide
the most valuable type of evidence: proof of effectiveness and a probability that the new ther-
apy will be applicable in large populations in the future largely increased.
The academic literature shows no indication that choices regarding the dissemination of
diabetes news are affected by the research phase of the presented innovation. Innovations in all
stages of research are discussed in news media. Although lay readers might not be able to dif-
ferentiate between evidence from different clinical phases, such messages may still affect treat-
ment perceptions and emotions. This assumption is supported by research findings showing
that the preclinical phase (e.g., research on animals) elicited the most positive emotions among
diabetes patients on Facebook [12]. Persons with knowledge of clinical research may presum-
ably perceive a qualification like ’successful in patients’ as news with higher actual success
chances. However, overly optimistic perceptions might potentially harm treatment adherence,
Literature by Mann et al. [13] showed that disease and medication beliefs that were inconsis-
tent with a chronic disease model of diabetes were significant predictors of poor medication
adherence.
News source: Authority of the news source
The accessibility of the internet and the low cost to spread information has led to increased
access to and dissemination of health information. Patients seeking health information
encounter large quantities of information from various sources and of varying quality and
accuracy. The new digital era entails a significant challenge in assessing the credibility of health
news [14]; and this is also true for diabetes news [15]. Particularly relevant is the source of
health information since important health-related behaviors and decisions are based on the
perceived credibility of the source [16]. On the internet, perceived credibility is determined by
the authority of the administrator of a website or platform, representative of the expertise, and
the trustworthiness of its writers of health information [17, 18].
The primary source of a health message frequently is a research institute or academic press
release. Nonprofessional websites without authority repeatedly are selecting sources of health
information [19]. Most health news messages reach the public through a broad range of select-
ing sources, varying from governmental health institutes to information gatekeepers such as
news anchors, reporters, and journalists who select and present health news messages for their
public. In the online context, technological interfaces such as web-based search engines and
social media like Facebook function as selective sources, filtering and forwarding health news
messages of primary sources [20].
Interestingly, online networks also enable receivers of health information to select and
transfer health news messages themselves (whether or not assisted by technological interfaces).
Examples of such receiving sources are moderators and members of online support groups,
Facebook groups, chat rooms, and discussion forums. Online users of health news information
may establish the selecting sources’ credibility based on the perceived degree of expertise in
these sources. In Western societies, credibility will be estimated higher in expert-based, autho-
rized sources such as government health institutes, and lower in nonprofessional sources such
as Facebook groups. In line with the Elaboration Likelihood Model of Persuasion [21], it is
expected that sources with a clear scientific origin–such as universities or governmental insti-
tutions–will, by rule of thumb, lead to higher perceptions of a message’s credibility and accu-
racy. News messages coming from authoritative sources may therefore increase estimations
that the innovation will eventually be successful and personally useful. Further, it can be
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hypothesized that the authority of the source plays a crucial role in opinion formation and
change especially to those (patients) who are less inclined to seek news on the topic and thus
are less likely to take the time to elaborate on the actual arguments in the message through the
central route.
News style: Language intensification
Health news regularly contains powerful language that is used by the author to increase its viv-
idness and attention value. Although this so-called language intensification is a complex con-
cept [22], a functional definition is the use of language that is used to deviate from neutrality
[23]; in the present case, that is deviating towards the positive aspect. Strong words such as
breakthrough, enormous, very important, or lifesaving in a sentence intensify, by inserting
pars pro toto’ superlatives’, a statement that otherwise would be more factual; this phenome-
non is not strange to coverage of medical news [24] and may affect the reader. Although over-
all results are mixed, several studies show that the use of language intensifiers increases the
clarity of the message [25, 26]. In another study, language intensification led to high message
elaboration by receivers: after reading intensified language, patients were better able to distin-
guish stronger from weaker arguments [27]. In experimental studies, the high-intensive lan-
guage had a more positive influence on attitudes and intentions than low-intensive language
[28]. Also, some studies suggest that language intensification may influence behavior [29].
In contrast, a study on perceptions of health news messages showed that these were mostly
affected by objective risk characteristics; language intensification only affected readers’ percep-
tions of the severity of a health risk [30]. These findings suggest that readers of health news
have the ability to correct for language intensification and see the objective part of the informa-
tion. Although the use of language intensification is common practice in health news coverage,
specific effects of adding strong words to health news, on outcomes (i.e., attitudes, and behav-
ioral intentions) among patient populations are yet unknown. The present study compared
intensified with factual text versions, to assess effects on the value that diabetes patients attach
to the news message content, and thus on their estimations that the presented innovation will
be successful. Furthermore, the study assessed effects on interest in the given innovation and
attitudes towards current lifestyle advice and therapy adherence attitudes and intentions.
Despite excessive media attention for clinically unproven innovations and existing worries
about this phenomenon among experts [8, 31, 32], the actual effects of such media coverage on
patients have not been established in empirical research. It is known that characteristics of
news messages are associated with emotions [12, 33, 34], but empirical evidence on patients’
attitudes and behaviors to continue a challenging lifestyle program or medication regimen is
lacking. The current study aims to gather first insights into the possible impact of reading
about promising medical research, varying the typical characteristics of scientific health news.
Focus is put on dependent outcomes that represent perceptions and attitudes regarding the
presented innovation in the news, and regarding the current treatment that the patients
receive. The outcomes may be considered determinants of actual therapy adherence behavior
[35].
To measure news effects on these outcomes, we present fictional innovations in short mes-
sages that are systematically manipulated on three news dimensions; object, source, and style,
that is: (a) the developmental phase of a particular innovation; (b) the type of authority of the
source on the innovation news message; and (c) the degree of language intensification by in-
text presence of strong words to emphasize the innovative research results.
Based on the literature and the guidelines outlined above, the research questions that
guided the current research were as follows:
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Research question. When patients diagnosed with diabetes read news messages about
innovative ways to treat their disease in the future: to what extent do news message characteris-
tics (i.e. developmental phase of the innovation, authority of the news source, and language
intensification) affect patients’ (i) expectations of the innovation’s success, (ii) interest to gain




Human participants were involved in an online vignette experiment. The local review board
�UPPER (Utrecht University)� approved our study protocol (September 28th, 2018; UPF1806)
and declared that the study did not fall under the scope of the “Medical Research Involving
Human Subjects Act”. Prior to start of the actual digital survey, patients were informed about
the aims and burden of the study and consent was given by a click to accept principle. Because,
no names and other identifying information was requested, a signed consent form was not
required.
Diabetes patients for the present online vignette study were recruited both on social media
and in pharmacies. Patients were invited by posting a link on three Dutch diabetes-related
forums and 14 diabetes Facebook groups (October 2018 –January 2019). With the approval of
the website owners or moderators, a recruitment text with a request to participate in an online
questionnaire about Diabetes News and Reader’s Mood was posted together with the survey
link. In the same period, 25 Dutch pharmacies agreed to contribute to our research by handing
out flyers containing a recruitment text and a weblink to customers treated for diabetes melli-
tus type 1 or 2. All participants were volunteers and remained anonymous.
To include sufficient patients in our experiment, we determined a clinically significant
increase of interest in an innovation of 0.5 on a 5 point Likert scale (with a standard deviation
for the population of 1.0). A sample size calculation for an exploratory study with alpha 0.05
and power 0.80 predicted a necessary sample size of 63 per experimental group. To detect dif-
ferences between two authority types, two language intensity types or three developmental
phases, we needed a total of 126 to 189 participants.
The present experiment consisted of a three-factor between-subjects design, using vignettes,
i.e., short descriptions of imaginary situations. Participants were randomly assigned to one
vignette that varied on three different dimensions: (1) three levels of the developmental phase
that the presented innovation could be in, (2) two types of authority of the source, and (3) two
degrees of language intensification (see Measures section). This design resulted in a total of
twelve (3x2x2) unique text combinations and the messages were matched on diabetes type
(type 1 and 2). Although a within-subjects design may result in more power to detect differ-
ences, it would come at the potential costs of a lower external validity and a higher dropout
rate. Moreover, the present research anticipated that reading the second vignette in a short
period of time may have led to decreased emotional responses.
Materials and procedure
Our data was collected in Lime Survey and was exported to a protected University network
environment. No data was saved that can lead to tracing individual participants of the study.
After giving consent for participating, all participants indicated their age and whether they
were diagnosed with either type 1 or type 2 diabetes mellitus. Those not diagnosed with diabe-
tes, or having an age under 18 years, were thanked for their interest, and the questionnaire
automatically ended. There were no other in- or exclusion criteria. The remaining participants
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were then asked to read one of 12 experimental news texts that were shown in visual frames
(Figs 1 and 2). The survey software matched the fictional news messages to typical innovations
for either diabetes mellitus type 1 or type 2. Thus, the messages were matched to specific diabe-
tes mellitus type, but this matching was not a factor (or: manipulation) in the vignette research
design.
To experimentally manipulate the presented scientific evidence for the innovation’s success,
we varied the developmental phases in the vignettes. Table 1 shows the three simplified stages
of diabetes research (levels of presented evidence) that we used. For the fundamental phase, we
presented the following statement: the innovation is soon ready to be tested in animals. Next,
to indicate that preclinical evidence (in animals) had already been found, we stated that the
therapy showed positive results in mice. Lastly, to indicate that actual clinical evidence in
patients was gathered, we stated that the treatment proved successful in 22 patients.
To suggest that the message was either visible on the website of (1) an authoritative govern-
mental source (i.e., Dutch National Institute for Public Health and Environment), or (2) from
a nonprofessional non-authoritative source (i.e., a Facebook group named Diabetes Facebook
Group without specified author).
To experimentally manipulate language intensification, we added four language intensifiers
(special, discovery, important, and promising) that are frequently used in Dutch medical news
to 50% of the presented vignettes, and this was added in combination with degree indicators
very, a lot, much, and many; all of these intensifiers were absent from the other 50%. The four
chosen intensifiers were identified after programmatically counting all words and identifying
potential text intensifiers that were written in 173 web-based news articles about diabetes that
we selected for earlier research.
After reading the experimental message, participants filled out a web-based baseline ques-
tionnaire that assessed four dependent outcomes (see Measures section): (1) perception of
Fig 1. The visual frame surrounding the news message suggests that the news message is published in an online diabetes Facebook
group.
https://doi.org/10.1371/journal.pone.0255587.g001
PLOS ONE Effects of diabetes news on patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0255587 August 19, 2021 6 / 16
successfulness of the innovation; (2) interest in the innovation; (3) attitude towards advised
lifestyle changes; (4) attitude towards adhering to medication regimes.
Measures
Factor analysis was conducted for 8 items measuring (1) estimations of future successfulness
and (2) interest in gaining additional information 3) intentions regarding the usefulness of
Fig 2. The visual frame surrounding the news message suggests that the news message is published on the website of an authority:
Netherlands National Institute for Public Health and the Environment (RIVM).
https://doi.org/10.1371/journal.pone.0255587.g002
Table 1. Factors and levels used in the construction of the vignettes.
Factor Level
Developmental phase Reported success in fundamental research stages: ’the therapy is soon ready to be tested in
mice’
Reported success in preclinical research on mice: ’In the last year, the therapy showed
positive results in mice’
Reported success in clinical research on patients: ’In the last year, the therapy showed
positive results in a group of 22 patients’
Source authority Source with authority: simulated website of the Dutch National Institute for Public Health
and Environment (RIVM)
Source without authority: a not further specified ’Diabetes Facebook Group’ simulation
Language
intensification
No intensified news content; base texts
Intensified news content; four common intensifiers added (special, discovery, important,
and promising)
https://doi.org/10.1371/journal.pone.0255587.t001
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previously received lifestyle advices (4) intentions regarding adhering to current medication
regimens. A principal component analysis was used to generate the factors. The Kaiser-Meyer-
Olkin (KMO) test was used for determining the sample adequacy. A value of more than 0.5
has been considered adequate to perform factor analysis [36]. The Bartlett test of Sphericity
was used to determine the homogeneity of the data. A Bartlett test p-value of less than 0.05 is
considered significant and useful for factor analysis [36]. Oblimin rotation was used after the
initial factor solution. The optimal number of factors was assessed from the scree plot. Find-
ings showed that the following four 2-item (5-point Likert) scales represented the four compo-
nents of our interest:
1. Two items assessed the patient’s expectations of the innovation’s success on a 5-point Likert
scale (strongly disagree–strongly agree): "The treatment I just read about will be successfully
used against diabetes in 10 years", and "The message I just read exaggerates the success of
the new treatment (reverse coded)" (Cronbach’s alpha = 0.69). The average score on this 2
item scale was used to answer research questions.
2. Two items assessed the patient’s interest to gain additional information on a 5-point Likert
scale (strongly disagree–strongly agree): "I will look up more information about this new
treatment", and "I will discuss this treatment with my health professional" (Cronbach’s
alpha = 0.83). The average score on this 2 item scale was used to answer research questions.
3. Two items assessed the patient’s intentions regarding received lifestyle advice: "It is wise to
follow lifestyle advice in the coming month", "I will follow the lifestyle advice that I received
in the coming month", (strongly disagree–strongly agree) (Cronbach’s alpha = 0.80). The
average score on this 2-item scale was used to answer research questions.
4. Two items assessed the patient’s intentions regarding current medication adherence: "It is
wise to take prescription medication in the coming month" I will take my own medication
as prescribed in the coming month" (strongly disagree–strongly agree) (Cronbach’s
alpha = 0.91). The average score on this 2-item scale was used to answer research questions.
Statistical analysis
Data were analyzed with SPSS Version 25.0 (SPSS, Inc, IL, USA) using unifactorial analyses of
variance with developmental phase, source platform, language intensification as independent
factors, and 3x2x2 ANOVA to assess interactions between independent variables. Effect sizes
were calculated with partial eta squared, with effect sizes of .01–.06 considered as small,
.06–.14 as medium and above .14 as large [37]. Descriptive analysis was carried out using
mean and standard deviation with the range for continuous variables, while frequency and
percentages were used for discontinuous ones. The present study did not use corrections for
multiple testing based on the exploratory nature of the research, with research questions but
without a prespecified key hypothesis. In exploratory studies multiple test adjustments are not
strictly required [38]. Moreover, corrections such as the Bonferroni correction may come at
the cost of missing a novel point of departure for studying new associations between indepen-
dents and clinical outcomes [39].
This study was part of a larger research project that aims to assess the effects of health news
characteristics on patient well-being; associations between patient characteristics and health
seeking preference will be reported elsewhere. To secure the outcomes of a random vignette
distribution, and possibly correct for unequal patient characteristics in the various vignette
groups, we were able to verify the equal distribution of different baseline characteristics: age,
gender, the estimated number of years since diabetes diagnosis, and current medication.
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Results
We collected data on independent and dependent variables from 259 participants. Table 2
shows the participant characteristics. Table 3 shows the random allocation to the vignette
manipulations. since a small number of the participating patients did not complete the full
questionnaire, the total number of patients in the various analyses shows a small variation
between 235 and 259 (see results section). Sensitivity analyses with these patients showed no
relevant differences in outcome between the subgroups (data available upon request).
Developmental phase
The ANOVA on patients’ expectations of the innovation’s success, entering the manipulation of
developmental phase as a fixed factor, showed a difference between the manipulated phases
with a small effect size (F(2, 258) = 3.81, p< .05, ηp2 = .029). The highest success chances were
perceived when success in mice was reported (M = 1.93, SD = 0.42). See Table 4.
No statistically significant main effects of the developmental phase were found on the other
dependent variables: interest in the presented innovation, and intentions regarding current
lifestyle and medication therapy adherence.
Source authority
The ANOVA on patients’ information intention, entering the manipulation of developmental
phase as a fixed factor showed that patients’ information intention was higher when the source
was not authoritative, (F(1, 256 = 4.79 p< .05, ηp2 = .018). In contrast, patients’ medication
adherence intention was higher when the source condition was authoritative (F(1, 236) = 8.52,
Table 2. Characteristics of the participants.
N = 259 Range












Years since diagnosis, mean (SD) 14.4 (12.1) <1–57
Medication use, n(%)
Insulin + other medication 63 (24.3)
Insulin only 106 (40.9)
Other medication only 71 (27.4)
No medication 19 (7.3)
1 Bachelor, Master.
2 Senior general secondary education (HAVO), university preparatory education (VWO), vocational education and
training (MBO 2,3,4).
3 Primary school, preparatory vocational secondary education (VMBO), Vocational education and training (MBO1).
https://doi.org/10.1371/journal.pone.0255587.t002
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p< .005, ηp
2 = .035). A similar pattern was observed for lifestyle intentions, but this effect was
not statistically significant. See Table 5 for Means and SDs.
Language intensification
The ANOVA on patients’ expectations of the innovation’s success, entering the manipulation of
language intensification as a fixed factor, showed no significant effect. Patients’ information
intention was higher in the no intensification condition, compared with the intensification
condition (F(1,255) = 3.93, p< .05, ηp2 = .015), with a small effect size. Furthermore, patients
had a higher lifestyle intention in the condition without language intensification, F (1,234) =
5.74, p< .05, ηp2 = .014. No significant effect was observed on the medication adherence inten-
tion. See Table 6.
Interaction effects
To assess interactions between the independent variables, 3 (developmental phase) x 2(source
authority) x 2(language intensification) ANOVAs were conducted on the dependent variables.
The analyses revealed no statistically significant (p< .05) interaction effects.
Discussion
Previous studies reported an abundance of accessible online health messages, frequently lack-
ing clarity regarding their therapeutic potential [8, 40, 41]. The present study assessed whether
such news characteristics affected diabetes patients’ expectations, interests, and attitudes
regarding the presented innovation and their current therapies. For the first time, a particular
focus was put on the persuasive effects of the reported developmental phase of the innovation
on perceptions and intentions. In biomedical research on innovative therapies, the evidence
for clinical effects in actual patients is vital, and earlier successes must be celebrated with
restraint. Only when therapeutic results are confirmed in actual patients, so-called proof of
concept is reached, which indicates that in this stage, innovations have improved chances to
succeed [11]. However, journalists frequently report about earlier developmental phases,
which may affect patients’ perceptions and adherence intentions different from situations
where better evidence is available.
This study found that, on average, patients estimate the future success chances of a pre-
sented diabetes innovation the highest when success in mice is shown and not when success in
patients is presented. Note that the power of the effects was limited and, remarkably, that
patients’ interest in gaining additional information did not increase by stating success in actual
Table 3. Distribution of vignette manipulations.
N = 259
Developmental phase, n (%)
Reported success in fundamental stage 88 (34.0)
Reported success in mice 84 (32.4)
Reported success in 22 patients 87 (33.6)
Language intensification, n (%)
Intensified 138 (53.3)
Not intensified 121 (46.7)
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patients. Apparently, patients are already quite convinced by the value of laboratory medicine,
unaware of the challenging translation from such inventions to healthcare innovations. [42] In
other words, it may be that patients did not carefully interpret essential signals about the level
of scientific evidence due to a lack of medical and healthcare knowledge. This may have
induced peripheral argument processing, following the so-called expert heuristic ("these scien-
tists can be trusted") rather than following the central route of full argument processing [43].
Especially in experimental settings such as our study, such an expert heuristic may eliminate
developmental phase-related persuasive effects that require more cognitive elaboration. In
addition, for laymen (such as our participants), the reference to ‘mice’ in the laboratory
Table 4. Results one-way ANOVA: between group differences as filled in on a 5 point likert scale 0–4; mean/neutral = 2.0 (Developmental phase).
Developmental phase, expressed by Success
1: ’Soon ready for research on mice’ Mean
(SD)
2: Success in mice’ Mean
(SD)






Expectations of the innovation’s
success
1.74(0.44) 1.93(0.42) 1.78(0.52) F(2,258) =
3.81
n = 88 n = 84 n = 87 p = .023�
ηp
2 = .029
Interest to gain additional
information
1.72(1.17) 1.70(1.18) 1.40(1.04) F (2,256) =
2.25
n = 87 n = 83 n = 87 p = .11
ηp
2 = .017
Lifestyle intention 3.05(0.89) 3.03(0.74) 2.84(0.97) F (2,234) =
1.42
n = 83 n = 75 n = 77 p = .25
ηp
2 = .012
Medication adherence intention 3.40(1.07) 3.21(1.05) 3.46(0.75) F (2,236) =
1.38




Table 5. Results one-way ANOVA: between group differences as filled in on a 5 point likert scale 0–4; mean/neutral = 2.0 (Source authority).
Source authority
Authority No authority F statistic
P value
ηp2 =
Expectations of the innovation’s success 1.81(0.50) 1.83(0.42) F (1,258) = 0.12
n = 132 n = 127 p = .73
ηp
2 = .000
Interest to gain additional information 1.45(1.09) 1.76(1.16) F (1,256) = 4.79
n = 131 n = 126 p < .029�
ηp
2 = .018
Lifestyle intention 3.08(0.83) 2.87(0.90) F (1,234) = 3.24
n = 117 n = 118 p = .073
ηp
2 = .014
Medication adherence intention 3.54(0.77)� 3.18(1.11�) F (1,236) = 8.52
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evidence may function as a rather prototypical cue that the evidence is indeed scientific evi-
dence, and this ‘mice’ reference may thus in fact have reinforced, rather than diminished, the
aforementioned expert heuristic.
Additional support for the explanation that at least some patients may have processed infor-
mation via the peripheral route, comes from the effects of the manipulating factor source
authority: results showed that when the news was brought by an authoritative professional
source, it increased patients’ intention to adhere to current medication regimens, in compari-
son to reading the same message when brought by a non-authoritative, nonprofessional
source. The improved adherence intentions in the authoritative source version may be
explained by the persuasive power that authorities such as the National Institute for Public
Health and the Environment (RIVM) in the Netherlands have. The positive cues that partici-
pants received from recognizing this authority may have led to simple merit conclusions and
quick information processing in the peripheral route [43]. However, our study also showed
that specifically the nonprofessional, non-authoritative source increased patients’ interest in
the innovation, which seems not directly in line with this theory. One possible explanation
may be that the interest is in fact a need to receive additional information which results from a
lower trust in non-authoritative message sources: information brought by such sources is in
need of further elaboration and verification.
Remarkably, our findings suggest that intensifying medical news with strong language such
as promising, very, or breakthrough, is counterproductive when trying to serve a patient com-
munity. Although effect sizes were small, they indicate that using intensified language
decreases rather than increases patients’ interest in the presented innovation and even slightly
lower patients’ intentions to follow current lifestyle advice. This unexpected, reversed, effect of
language intensification in our study may be explained when taking into account that intensi-
fied language in the context of our study may have been perceived as an expression of subjec-
tivity. Linguistically, intensification foregrounds the involvement, or stance, of the author and
as such, it contributes to the emotive and subjective dimension of discourse [44, 45]. Subjective
intensification may therefore be perceived–either consciously or subconsciously—as framing
bias, in which the author or speaker takes a particular position on arguable topics such as
anticipating a better future [46]. In a context in which patients are expectant of trustworthy,
Table 6. Results one-way ANOVA: between group differences as filled in on a 5 point likert scale 0–4; mean/neutral = 2.0 (Language intensification).
Language intensification




Expectations of the innovation’s success 1.83(0.48) 1.80(0.45) F (1,258) = .34
n = 121 n = 138 p = .56
ηp
2 = .001
Interest to gain additional information 1.75(1.21) 1.47(1.06) F (1,256) = 3.93
n = 120 n = 137 p = .048�
ηp
2 = .015
Lifestyle intention 3.12(0.85) 2.85(0.87) F (1,234) = 5.74
n = 112 n = 123 p = .026�
ηp
2 = .024
Medication adherence intention 3.29(1.07) 3.42(0.87) F (1,236) = 1.03
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factual descriptions of future treatment options, this non-neutral position of the author may
thus weaken the persuasiveness of the news message. Note that in the context of news stories
on research, language intensification must be distinguished from spin, which was found to
increase readers’ estimates of future success of the presented therapy [47]. However, spin, i.e.
the conscious or unconscious misrepresentation of study results that overemphasize the effi-
cacy or safety of the treatment; in the current study, was not included in the current study.
Limitations and future directions
The current study has some limitations. First, anonymous patients were recruited online, and
it was not possible to verify their self-reported medical information. Second, a large part of the
online recruitment was performed in Facebook groups. This may have led to bias regarding
Facebook-related perceptions and opinions since these patients are more used to this social
media platform than the whole diabetes population may be. Possibly, participating patients
that were recruited from Facebook put more trust in non-authoritative sources while holding
a relative distrust towards official authorities. Yet, most of the cooperating Facebook Groups
were either linked to large diabetes patient associations that do not oppose science nor medical
authorities in any way, or were acting as a conduit for scientific news from universities and
other scientific authorities. Moreover, it is this specific population that is most frequently
online and reading news on Facebook groups, and can, therefore, be considered as our pri-
mary target population. Another limitation may be the absence of a control group that did not
read the news at all. The implication of not including this third group is that questions with
respect to reading versus not reading news, remain unanswered. However, the odds are low
that in a real-world situation, patients will never read health news messages. The last limitation
may be the use of parametric tests on data from 5 point Likert scales. Although it has become
common practice to perform parametric tests on 5-point scales, some researchers oppose the
idea that differences between neutral, agree, and strongly agree are equal and linear steps [48].
Future research should aim at effects on emotional wellbeing as well as on determining spe-
cific vulnerable patient groups that are more susceptible to effects than our general population
on average was. This can preferably be done by using a longitudinal observational design con-
taining actual media exposure measures on patients from susceptible groups. Furthermore, it
may be important to understand if, and how, patients are affected by news on social media
accounts of professionals in the medical fields, specifically physicians and scientists. Another
limitation is the power of our study. The number of patients that we included was large enough
to detect 0.5 point differences on the 5p Likert scales. However, for detecting such a difference
in two-way interactions (e.g. source authority x developmental phase) the eventual number of
participants was about fifty percent too low. This is a possible explanation for the absence of
interaction effects. Hence, we recommend future studies to repeat our experiments with higher
power since clinical relevant differences may still exists in diabetes groups. Lastly, research
needs to be performed on patients’ understanding and perceptions of medical developments
and on possible education: what do patients comprehend, and how much knowledge of cur-
rent diabetes research is necessary to optimize information provision and quality of life.
Conclusions
The present experimental study presented diabetes patients with news about relevant medical
innovations, to assess whether specific news characteristics, i.e., the developmental phase of an
particular innovation; the authority of the source; and the language intensification degree of
the message, affect patients’ perceptions of the presented innovation and their current therapy
adherence intentions. Large effects were not found. A small but significant effect that was
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established is an increase of the intention to adhere to medication after reading news from an
authoritative source. Though limited, this effect is may yet be of importance, given the large
and greatly varied diabetes population that encounters an ever increasing amount of online
health news. From an overarching viewpoint, the results of our study support an optimistic
view that patients diagnosed with diabetes, as they are generally critical assessors of health
news. Future research on this topic should above all focus on affected fragile subgroups.
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15. Nordfeldt S, Ängarne-Lindberg T, Nordwall M, Krevers B. Parents of adolescents with type 1 diabetes-
their views on information and communication needs and internet use. A qualitative study. PloS one.
2013 Apr 23; 8(4):e62096. https://doi.org/10.1371/journal.pone.0062096 PMID: 23626772
16. Dubbeldam I, Sanders J, Spooren W, Meijman FJ, van den Haak M. Motives for health information
behavior: Patterns more refined than traditional dichotomies. A Study among women in a Cervix Treat-
ment Process. Journal of consumer health on the internet. 2018 Apr 3; 22(2):126–41.
17. Hu Y, Shyam Sundar S. Effects of online health sources on credibility and behavioral intentions. Com-
munication research. 2010 Feb; 37(1):105–32.
18. Al-Maskari F, El-Sadig M, Al-Kaabi JM, Afandi B, Nagelkerke N, Yeatts KB. Knowledge, attitude and
practices of diabetic patients in the United Arab Emirates. PloS one. 2013 Jan 14; 8(1):e52857. https://
doi.org/10.1371/journal.pone.0052857 PMID: 23341913
19. Sundar SS, Nass C. Conceptualizing sources in online news. Journal of communication. 2001 Mar 1;
51(1):52–72.
20. McClain CR. Practices and promises of Facebook for science outreach: Becoming a “Nerd of Trust”.
PLoS biology. 2017 Jun 27; 15(6):e2002020. https://doi.org/10.1371/journal.pbio.2002020 PMID:
28654674
21. Petty RE, Cacioppo JT. The elaboration likelihood model of persuasion. InCommunication and persua-
sion 1986 (pp. 1–24). Springer, New York, NY.
22. Liebrecht, C. Intens krachtig. Stilistische intensiveerders in evaluatieve teksten. Doctoral dissertation,
Radboud University Nijmegen. 2015
23. Bowers JW. Language intensity, social introversion, and attitude change. Communications Mono-
graphs. 1963 Nov 1; 30(4):345–52.
24. Abola MV, Prasad V. The use of superlatives in cancer research. JAMA oncology. 2016 Jan 1; 2
(1):139–41. https://doi.org/10.1001/jamaoncol.2015.3931 PMID: 26512913
25. Hamilton MA, Hunter JE, Burgoon M. An empirical test of an axiomatic model of the relationship
between language intensity and persuasion. Journal of Language and Social Psychology. 1990 Dec; 9
(4):235–55.
26. McEwen WJ, Greenberg BS. The effects of message intensity on receiver evaluations of source, mes-
sage and topic. Journal of communication. 1970 Dec; 20(4):340–50.
27. Craig TY, Blankenship KL. Language and persuasion: Linguistic extremity influences message pro-
cessing and behavioral intentions. Journal of Language and Social Psychology. 2011 Sep; 30(3):290–
310.
28. Bankhead TD, Bench A, Peterson T, Place R, Seiter JS. Intensity and color of language in attitude
change and emotion. Perceptual and motor skills. 2003 Apr; 96(2):492–4. https://doi.org/10.2466/pms.
2003.96.2.492 PMID: 12776832
29. Andersen P., & Blackburn T. An experimental study of language intensity and response rate in e mail
surveys. Communication Reports, 2004 17(2), 73–84
30. Klemm C, Hartmann T, Das E. Fear-Mongering or Fact-Driven? Illuminating the Interplay of Objective
Risk and Emotion-Evoking Form in the Response to Epidemic News. Health Communication. 2019 Jan
2; 34(1):74–83. https://doi.org/10.1080/10410236.2017.1384429 PMID: 29058483
31. Schwitzer G. Pollution of health news. BMJ: British Medical Journal (Online) 2017, 356. https://doi.org/
10.1136/bmj.j1262 PMID: 28298320
32. Sumner P, Vivian-Griffiths S, Boivin J, Williams A, Bott L, Adams R, et al. Exaggerations and caveats in
press releases and health-related science news. PloS one. 2016 Dec 15; 11(12):e0168217. https://doi.
org/10.1371/journal.pone.0168217 PMID: 27978540
PLOS ONE Effects of diabetes news on patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0255587 August 19, 2021 15 / 16
33. Nabi RL, Prestin A. Unrealistic hope and unnecessary fear: Exploring how sensationalistic news stories
influence health behavior motivation. Health communication. 2016 Sep 1; 31(9):1115–26. https://doi.
org/10.1080/10410236.2015.1045237 PMID: 26886401
34. Sumner P, Vivian-Griffiths S, Boivin J, Williams A, Venetis CA, Davies A, et al. The association between
exaggeration in health related science news and academic press releases: retrospective observational
study. BMJ. 2014 Dec 9; 349:g7015. https://doi.org/10.1136/bmj.g7015 PMID: 25498121
35. Fai EK, Anderson C, Ferreros V. Role of attitudes and intentions in predicting adherence to oral diabe-
tes medications. Endocrine connections. 2017 Feb 1; 6(2):63–70. https://doi.org/10.1530/EC-16-0093
PMID: 28087609
36. Tabachnick BG, Fidell LS, Ullman JB. Using multivariate statistics. Boston, MA: Pearson; 2007 Mar 3.
37. Cohen J. Statistical power analysis for the behavioral sciences ( 2nd ed.). Hillsdale, NJ: Erlbaum. 1988
38. Noble WS. How does multiple testing correction work?. Nature biotechnology. 2009 Dec; 27(12):1135–
7. https://doi.org/10.1038/nbt1209-1135 PMID: 20010596
39. Bender R, Lange S. Adjusting for multiple testing—when and how?. Journal of clinical epidemiology.
2001 Apr 1; 54(4):343–9. https://doi.org/10.1016/s0895-4356(00)00314-0 PMID: 11297884
40. Haneef R, Lazarus C, Ravaud P, Yavchitz A, Boutron I. Interpretation of results of studies evaluating an
intervention highlighted in Google health news: a cross-sectional study of news. PloS one. 2015 Oct 16;
10(10):e0140889. https://doi.org/10.1371/journal.pone.0140889 PMID: 26473725
41. Ioannidis JP, Stuart ME, Brownlee S, Strite SA. How to survive the medical misinformation mess. Euro-
pean journal of clinical investigation. 2017 Nov; 47(11):795–802. https://doi.org/10.1111/eci.12834
PMID: 28881000
42. Price C. P., & John A. S. (2014). Innovation in healthcare. The challenge for laboratory medicine. Clinica
chimica acta, 427, 71–78. https://doi.org/10.1016/j.cca.2013.09.043 PMID: 24113488
43. Petty RE, Cacioppo JT. The elaboration likelihood model of persuasion. InCommunication and persua-
sion 1986 (pp. 1–24). Springer, New York, NY.
44. Athanasiadou A. On the subjectivity of intensifiers. Language sciences. 2007 Jul 1; 29(4):554–65.
45. Vis K, Sanders J, Spooren W. Diachronic changes in subjectivity and stance–A corpus linguistic study
of Dutch news texts. Discourse, Context & Media. 2012 Jun 1; 1(2–3):95–102.
46. Recasens M, Danescu-Niculescu-Mizil C, Jurafsky D. Linguistic models for analyzing and detecting
biased language. In Proceedings of the 51st Annual Meeting of the Association for Computational Lin-
guistics (Volume 1: Long Papers) 2013 Aug (pp. 1650–1659).
47. Boutron I, Haneef R, Yavchitz A, Baron G, Novack J, Oransky I, et al. Three randomized controlled trials
evaluating the impact of “spin” in health news stories reporting studies of pharmacologic treatments on
patients’/caregivers’ interpretation of treatment benefit. BMC medicine. 2019 Dec 1; 17(1):105. https://
doi.org/10.1186/s12916-019-1330-9 PMID: 31159786
48. Jamieson S. Likert scales: How to (ab) use them?. Medical education. 2004; 38(12):1217–8. https://doi.
org/10.1111/j.1365-2929.2004.02012.x PMID: 15566531
PLOS ONE Effects of diabetes news on patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0255587 August 19, 2021 16 / 16
